Patents by Inventor Isabelle Hemming

Isabelle Hemming has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12140468
    Abstract: The invention relates to a method for dosing a target component (20), wherein a dosing system (10) doses the target component (20) to a target value (Z20), which corresponds to a desired nominal value (S20soll), wherein an additional dosing system (12) doses at least one additional component (21, 22, 23) to be follow-on dosed, to a target value (Z21) of the component (21, 22, 23) to be follow-on dosed which is lower than a desired nominal value (S21soll) of the component (21, 22, 23) to be follow-on dosed, wherein an actual value (G20ist) of the target component (20) and at least one actual value (G21ist) of the component (21, 22, 23) to be follow-on dosed are then determined, a content (A) of the target component (20) then being calculated according to the actual value (G20ist) of the target component (20) and/or the actual value (G21ist) of the component (21, 22, 23) to be follow-on dosed and the content (A) being compared to a limit value (T) or tolerance band (T), at least the component (21, 22, 23) to be
    Type: Grant
    Filed: September 9, 2020
    Date of Patent: November 12, 2024
    Assignee: Hüttlin GmbH
    Inventors: Syed Muhammad Mushahid Azher, Christian Gebauer, Christian Karl Paasche, Marc Michaelis, Isabelle Hemming
  • Publication number: 20220214207
    Abstract: The invention relates to a method for dosing a target component (20), wherein a dosing system (10) doses the target component (20) to a target value (Z20), which corresponds to a desired nominal value (S20soll), wherein an additional dosing system (12) doses at least one additional component (21, 22, 23) to be follow-on dosed, to a target value (Z21) of the component (21, 22, 23) to be follow-on dosed which is lower than a desired nominal value (S21soll) of the component (21, 22, 23) to be follow-on dosed, wherein an actual value (G20ist) of the target component (20) and at least one actual value (G21ist) of the component (21, 22, 23) to be follow-on dosed are then determined, a content (A) of the target component (20) then being calculated according to the actual value (G20ist) of the target component (20) and/or the actual value (G21ist) of the component (21, 22, 23) to be follow-on dosed and the content (A) being compared to a limit value (T) or tolerance band (T), at least the component (21, 22, 23) to be
    Type: Application
    Filed: September 9, 2020
    Publication date: July 7, 2022
    Inventors: Syed Muhammad Mushahid Azher, Christian Gebauer, Christian Karl Paasche, Marc Michaelis, Isabelle Hemming